1-Year Follow up to the 1473-IMIQ Study

NCT00114023 · clinicaltrials.gov ↗

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratosis

Interventions

DRUG: Imiquimod 5% cream

Sponsor

Graceway Pharmaceuticals, LLC